This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has spread from where it first started (primary site) to other places in…
- Investigator
- Thomas J George
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All